Will new FDA meeting on Avandia prompt withdrawal of drug?

The FDA has announced that two of its panels will discuss the reanalysis of the controversial RECORD trial with the much-maligned diabetes drug rosiglitazone in June.
Source: theHeart.org - Category: Cardiology Source Type: news